000 | 01887 a2200553 4500 | ||
---|---|---|---|
005 | 20250516014606.0 | ||
264 | 0 | _c20110325 | |
008 | 201103s 0 0 eng d | ||
022 | _a1744-8042 | ||
024 | 7 |
_a10.2217/pgs.10.132 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMichelon, Hugues | |
245 | 0 | 0 |
_aSLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients. _h[electronic resource] |
260 |
_bPharmacogenomics _cDec 2010 |
||
300 |
_a1703-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiotransformation _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDNA _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 |
_aLeukocytes _xmetabolism |
650 | 0 | 4 | _aLiver-Specific Organic Anion Transporter 1 |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aKönig, Jörg | |
700 | 1 | _aDurrbach, Antoine | |
700 | 1 | _aQuteineh, Lina | |
700 | 1 | _aVerstuyft, Céline | |
700 | 1 | _aFurlan, Valérie | |
700 | 1 | _aFerlicot, Sophie | |
700 | 1 | _aLetierce, Alexia | |
700 | 1 | _aCharpentier, Bernard | |
700 | 1 | _aFromm, Martin F | |
700 | 1 | _aBecquemont, Laurent | |
773 | 0 |
_tPharmacogenomics _gvol. 11 _gno. 12 _gp. 1703-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.10.132 _zAvailable from publisher's website |
999 |
_c20433385 _d20433385 |